Metastatic prostate cancer Flashcards
What is abiraterone?
Oral androgen inhibitor for use in metastatic PC.
What is abiraterone licensed for?
1st line meta PC treatment where chemotherapy is noy yet clinically indicated: pt asymptomatic.
Also: after failure of HT or CT.
How does abiraterone work?
Inhibits androgen production from testes, adrenal gland and prostate tumour cells - all 3 sources of androgens in the body.
It is an irreversible inhibitor of CYP17A1 the enzyme responsible for androgen and cortisol production.
What must abiraterone be given with and why?
Must be given with a steriod (prednisolone 5mg PO bd).
Decreased cortisol causes a response by the hypothalamus that increases ACTH levels and the symptoms of cortisol deficiency e.g. Hypertension, fluid retention.
What is the enzyme that abiraterone blocks? is this reversible inhibition?
Abiraterone is an irrerversible inhibitor of CYP17A1 - enzyme responsible for androgen and cortisol production.
What is the normal dose of abiraterone?
1g daily without food (decreased BA?)
Abiraterone prolongs overall survivial by ___ months in pts who have had prior chemotherapy.
3-4 months.
overall survival 11-15
What impact does abiraterone have on pain?
Reduces pain.
Why does abiraterone need to be given with prednisolone?
It decreases cortisol leading to symptoms of cortisol deficiency such as hypertension, hypokalaemia, fluid retention.
What are the side effects of abiraterone?
Peripheral oedema. Hypokalaemia. Hypertension. UTI Elevated LFTs - monitor every 2 weeks for 1st 3 months.
What is enzalutamide?
Potent androgen receptor signalling inhibitor that blocks several steps in the androgen receptor signalling pathway. New hormonal treatment.
Inhibitor of the binding of androgens to androgen receptors, inhibitor of nuclear translocation of activated receptors and thus reduced associated of activated androgen receptors with DNA.
Enzalutamide.
How often do LFTs need to be monitored for abiraterone?
Every 2 weeks for 3 months.
CYP17A1 inhibitor
Abiraterone, irrerversible.
Must be given with a steroid.
Potent androgen receptor signalling inhibitor that blocks several steps in the androgen receptor signalling pathway. New hormonal treatment.
Enzalutamide